Aviptadil
Showing 1 - 9 of 9
SARS-CoV 2, COVID, ARDS Trial (ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or Placebo)
Withdrawn
- SARS-CoV 2
- +5 more
- ZYESAMI™ (aviptadil acetate)
- +2 more
- (no location specified)
Feb 2, 2023
Covid19, Corona Virus Infection, ARDS Trial in Liestal, St.Gallen (Aviptadil 67µg, Placebo 0.9% NaCl solution)
Recruiting
- Covid19
- +3 more
- Aviptadil 67μg
- Placebo 0.9% NaCl solution
-
Liestal, BL, Switzerland
- +1 more
Jun 22, 2022
SARS-CoV 2, COVID, ARDS Trial in United States (ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or
Terminated
- SARS-CoV 2
- +5 more
- ZYESAMI™ (aviptadil acetate)
- +2 more
-
Fullerton, California
- +12 more
Feb 2, 2023
Critical COVID-19 With Respiratory Failure Trial in United States (ZYESAMI (aviptadil acetate))
No longer available
- Critical COVID-19 With Respiratory Failure
- ZYESAMI (aviptadil acetate)
-
Gilbert, Arizona
- +24 more
Jul 19, 2022
Critical COVID-19 With Respiratory Failure, Acute Respiratory Distress Syndrome (ARDS), Corona Virus Infection Trial in United
Completed
- Critical COVID-19 With Respiratory Failure
- +3 more
- Aviptadil by intravenous infusion + standard of care
- Normal Saline Infusion + standard of care
-
Fullerton, California
- +9 more
Sep 5, 2021
Covid19 Trial in Ankara, Istanbul (Inhaled Aviptadil, Placebo)
Recruiting
- Covid19
- Inhaled Aviptadil
- Placebo
-
Ankara, Turkey
- +2 more
Apr 26, 2021
Covid19 Trial in Brazil, United States (Remdesivir, Remdesivir Placebo, Aviptadil)
Completed
- Covid19
- Remdesivir
- +4 more
-
Tucson, Arizona
- +39 more
Dec 16, 2022
